Stockreport

NRx Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call Transcript [Seeking Alpha]

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF Michael Abrams - Chief Financial Officer Jonathan Javitt - Co-Founder, Chief Scientist Officer, Chairman & Interim CEO Conference Call Participants Thomas Shrader [Read more]